Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-05

Clinical Trial Update: Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics and safety of dexlansoprazole in adolescents with gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexilant (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 1 | Status: COMPLETED | Results posted: 2010-10-05